Published January 2011
| Version v1
Journal article
Medium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotron
Creators
- 1. Hevesy Laboratory, Radiation Research Department, Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, P.O. 49, DK-4000 Roskilde (Denmark)
Description
In recent years the use of radionuclides in targeted cancer therapy has increased. In this study we have developed a high-current solid target system and demonstrated that by the use of a typical low-energy medical cyclotron, it is possible to produce tens of GBq's of many unconventional radionuclides relevant for cancer therapy such as 64Cu and 119Sb locally at the hospitals.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.apradiso.2010.07.019Additional details
Identifiers
- DOI
- 10.1016/j.apradiso.2010.07.019;
- PII
- S0969-8043(10)00305-2;
Publishing Information
- Journal Title
- Applied Radiation and Isotopes
- Journal Volume
- 69
- Journal Issue
- 1
- Journal Page Range
- p. 1-7
- ISSN
- 0969-8043
- CODEN
- ARISEF
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 42012739
- Subject category
- S07: ISOTOPES AND RADIATION SOURCES;
- Descriptors DEI
- ANTIMONY 119; COPPER 64; CYCLOTRONS; ELECTRONS; ISOTOPE PRODUCTION; NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY
- Descriptors DEC
- ACCELERATORS; ANTIMONY ISOTOPES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; COPPER ISOTOPES; CYCLIC ACCELERATORS; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; ELEMENTARY PARTICLES; FERMIONS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LEPTONS; MATERIALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.